Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 2,223 | 1,988 | 1,939 | 2,043 | 1,742 |
| Gross Profit | 2,223 | 1,988 | 1,939 | 2,043 | 1,742 |
| Operating Expenses | 18,405 | 13,512 | 13,208 | 7,585 | 6,610 |
| Operating Income | -16,182 | -11,524 | -11,269 | -5,542 | -4,868 |
| Interest Expense | 353 | 376 | 718 | 408 | 230 |
| Other Income | 509 | 415 | 120 | 149 | -1,113 |
| Pre-tax Income | -16,026 | -11,485 | -11,867 | -5,801 | -6,211 |
| Income Tax | 3 | 2 | 3 | 5 | N/A |
| Net Income Continuous | -16,029 | -11,487 | -11,870 | -5,806 | -6,211 |
| Net Income | $-16,029 | $-11,487 | $-11,870 | $-5,806 | $-6,211 |
| EPS Basic Total Ops | -0.44 | 24.59 | -14.26 | -7.56 | -7.67 |
| EPS Basic Continuous Ops | -0.44 | 19.33 | -11.41 | -5.80 | -6.23 |
| EPS Diluted Total Ops | -0.44 | 24.59 | -14.26 | -7.56 | -7.67 |
| EPS Diluted Continuous Ops | -0.44 | 19.33 | -11.41 | -5.80 | -6.23 |
| EBITDA(a) | $-15,477 | $-10,825 | $-10,524 | $-4,919 | $-4,463 |